Table 1 Tumour histology and grading of morphologies found in the patient groups of tamoxifen and unexposed, categorised into Type I, Type II or others
Endometrial tumours | N | TAM 29 | EC 37 |
|---|---|---|---|
TYPE I | |||
G1 endometroid | 15 | 3 | 12 |
G2 endometroid | 7 | 2 | 5 |
TYPE II | |||
G3 endometroid | 7 | 1 | 6 |
Uterine papillary serous carcinoma | 7 | 5 | 2 |
Clear-cell endometroid | 4 | 1 | 3 |
Carcinosarcoma | 14 | 8 | 6 |
Mixed carcinoma | 8 | 5 | 3 |
OTHERS | |||
Simple hyperplasia | 1 | 1 | 0 |
Complex atypical hyperplasia | 1 | 1 | 0 |
Endometrial polyp | 0 | 0 | 0 |
Endometrial polyp with stromal hyperplasia | 1 | 1 | 0 |
Inactive endometrium | 0 | 0 | 0 |
Menstrual endometrium (progestagen effect) | 0 | 0 | 0 |
Proliferative | 1 | 1 | 0 |
Secretory | 0 | 0 | 0 |
